ArticleDiagnostic pathology2012

High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.

Björn Nodin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.